SC dismisses plea against Ranbaxy Laboratories

The petitioner alleged that despite Ranbaxy pleading guilty, the Centre has not taken any action to prohibit or ban the drugs made by the company.

Ranbaxy issue a wake up call for Indian pharma industry: Shaw

The USD 500 million fine on Ranbaxy by US authorities after it pleaded guilty to "felony charges" for violating drug manufacturing norms is "a wake up call" for Indian pharmaceutical industry, according to Biocon Chairman and Manging Director Kiran Mazumdar-Shaw.

Take steps to stop use of adulterated drugs in India: Sachar

"How is that US authorities find them unfit for use but our whole set up in the government continues to permit it. Is it inefficiency, collusion or worse -- I do not know," Sachar said in a statement.